AYOXXA
Cologne
About AYOXXA
AYOXXA is a biotech company commercializing innovative technology developed at the National University of Singapore (NUS). AYOXXA’s patented technology platform is producing a new generation of biochips – merging biology with IT. This allows the biochip to accumulate large numbers of applications – measuring multiple protein markers for cancer, allergies, cardiovascular and infectious diseases – in a single test.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.0M
- Last round: Series Unknown (Mar 2022)
- Website: ayoxxa.com
- Phone: (221) 222-5290
Industries & Categories
Biotechnology, Information Technology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ayoxxa-2446508 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.